Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies-Reference-Cited by-同舟云学术

Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies

Published:2018-02-12 Issue:2 Volume:9 Page:623-636
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Kadowaki Takashi,Sasaki Kazuyo^ORCID,Ishii Manabu,Matsukawa Miyuki,Ushirogawa Yoshiteru

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-018-0372-x.pdf

Reference32 articles.

1. National Health and Nutrition Survey in Japan 2016; 2016. http://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/kekkagaiyou_7.pdf . Accessed 27 Oct 2017.

2. Ministry of Health Labour and Welfare, a basic direction for comprehensive implementation of National Health Promotion; 2012. http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000047330.pdf . Accessed 21 Aug 2017.

3. Araki E, Haneda M, Kasuga M, et al. New glycemic targets for patients with diabetes from the Japan Diabetes Society. J Diabetes Investig. 2017;8(1):123–5.

4. American Diabetes Association. Standards of medical care in diabetes—2018. Diabetes Care. 2018;40(Suppl 1):S1–159.

5. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of diabetes. Diabetologia. 2015;58(3):429–42.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice;Aging;2023-12-19

2. Application of Machine Learning Methods for the Development of Antidiabetic Drugs;Current Pharmaceutical Design;2022-02

3. Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study);Diabetes & Metabolism Journal;2022-01-31

4. Evaluation of the Safety and Efficacy of Teneligliptin at a Higher Dose in Indian Type 2 Diabetes Patients: A Retrospective Analysis;Cureus;2020-01-29

5. Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan;Advances in Therapy;2019-12-23